Our
Company
NorthStar is a radiopharmaceutical company, developing novel ways to help detect and cure cancer and other serious diseases. We are the first and only U.S. company housing commercial scale radioisotope production and radiopharmaceutical CDMO services co-located on the same campus.
We are routinely producing Copper-67 (Cu-67), used in clinical trials for the treatment of several types of cancer.
CREATIVE SOLUTIONS, WE
CLEARLY DEFINE
WHO
WE ARE
WE ARE
We are innovators who revolutionized the U.S. production of Mo-99, and now Cu-67. Actinium-225 (Ac-225) will begin production soon. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and radiopharmaceutical therapies that will serve the next generation of medical advances for patients.
The next major horizon includes a world class Radiopharmaceutical CDMO/CMO, launching production operations in early 2025.
